deltatrials
Completed PHASE2 INTERVENTIONAL 4-arm NCT06237049

A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults

A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA COVID-19 Vaccine and a Recombinant Influenza Vaccine Administered as a Single Injection in Healthy Adults 50 Years of Age or Older

Sponsor: Pfizer

Updated 9 times since 2024 Last updated: Sep 9, 2025 Started: Jan 31, 2024 Primary completion: Sep 13, 2024 Completion: Sep 13, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on COVID-19 and Influenza, Human, this trial is completed. The trial is conducted by Pfizer and has accumulated 9 data snapshots since 2024. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Mar 2024 – ~Apr 2024 · 31 days · monthly snapshot~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshotActive Not Recruiting~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshot~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – ~Nov 2024 · 31 days · monthly snapshot~Nov 2024 – ~Sep 2025 · 10 months · monthly snapshotCompleted~Sep 2025 – ~Oct 2025 · 30 days · monthly snapshot~Oct 2025 – present · 10 months · monthly snapshotCompleted

Change History

9 versions recorded
  1. Oct 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2025 — Oct 2025 [monthly]

    Completed PHASE2

  3. Nov 2024 — Sep 2025 [monthly]

    Completed PHASE2

    Status: Active Not RecruitingCompleted

  4. Oct 2024 — Nov 2024 [monthly]

    Active Not Recruiting PHASE2

  5. Sep 2024 — Oct 2024 [monthly]

    Active Not Recruiting PHASE2

Show 4 earlier versions
  1. Aug 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE2

  2. Jul 2024 — Aug 2024 [monthly]

    Active Not Recruiting PHASE2

  3. Apr 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE2

    Status: RecruitingActive Not Recruiting

  4. Mar 2024 — Apr 2024 [monthly]

    Recruiting PHASE2

    First recorded

Jan 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Pfizer
Data source: Pfizer

For direct contact, visit the study record on ClinicalTrials.gov .